Acorda Therapeutics Inc (ACORQ) Return on Investment ROI from the first quarter of 2024 to first quarter of 2023 and for the year 2024, average high and low, overall ranking from Mar 31 2024 to Mar 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Acorda Therapeutics Inc   (ACORQ)


Acorda Therapeutics Inc's ROI from its first quarter of 2024 to the first quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Acorda Therapeutics Inc's ROI in the first quarter of 2024?
Acorda Therapeutics Inc recorded a cumulative net loss of $-263 million during 12 months ending in the first quarter of 2024, resulting in a negative return on investment (ROI) of -704.7%.

Within the Healthcare sector 464 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2023 from 0 to 3652.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Investment Change TTM -86.86 % -53.94 % -29.48 % -34.1 % -28.95 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -186 -149 240 244 248
Return On Investment (TTM) - - -6.42 % -8.23 % -20.47 %
ACORQ's Overall Ranking # 3652 # 0 # 0 # 0 #
Seq. Investment Change TTM -74.39 % -41.22 % -2.31 % -10.65 % -10.23 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -263 -253 -16 -21 -58

ACORQ Company Profile >> Back to ACORQ Roi Comparisons >> See Annual ACORQ Return On Investment



Return On Investment ACORQ's Ranking
Within: No.
Industry # 58
Sector # 465
Overall # 3652

Return On Investment Statistics
High Average Low
9.25 %
-10.78 %
-37.5 %
(Dec 31 2018)   (Mar 31 2024)







Financial Statements
Acorda Therapeutics Inc's I. Quarter Investments $ -186 Millions ACORQ's Balance sheet
Acorda Therapeutics Inc's I. Quarter Income $ -27 Millions Quarterly ACORQ's Income Statement
ACORQ's Income by Division See ACORQ's Income by Division


ACORQ Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions -149 261 401 495 713
Y / Y Investment Growth - -35.07 % -18.97 % -30.55 % -38.47 %
Net Income in Millions -253 -66 -104 -100 -273
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -25.29 % -25.89 % -20.1 % -38.27 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ACORQ's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ACORQ's Competitors
Subscribers only: Roi for Acorda Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for ACORQ's Customers

Other Ratios
ACORQ's Roa ACORQ's Inventory Turnover Ratio ACORQ's Growth Rates ACORQ's Dividend Statistics
ACORQ's Profitability Ratios ACORQ's Asset Turnover Ratio ACORQ's Dividend Growth
ACORQ's Roe ACORQ's Valuation Ratios ACORQ's Financial Strength Ratios ACORQ's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2024, within Healthcare Sector ROI

Date modified: 2026-09-26T07:16:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.